The safety of our employees, customers and suppliers is our top priority.
In response to the elevated risks of the COVID-19 virus, GenomeScan is following the guidelines of the Dutch National Institute for Public Health and the Environment (RIVM) to ensure the well-being of its staff and guarantee business continuity.
We have also taken precautionary measures to prevent further spread of COVID-19 so that our employees can work in a safe environment (increased hygiene and reduced personal contact). During this period, we will guarantee access to our services and scientific support.
If you have any questions or concerns, please feel free to contact us at email@example.com or +31 71 568 1050.
The company leadership team, together with its stakeholders, regularly monitors the developments regarding coronavirus (COVID-19) around the country. We are committed to providing high quality services and with precautionary measures during the unprecedented times of coronavirus outbreak.
Since March 16th, 2020, we have sharpened the guidelines for visitors to prevent further spread of COVID-19 and guaranty the health and well-being of our employees, customers and suppliers. If your visit is critical to your project, it will require the approval of a member of our executive team.
Quality and Compliance
At GenomeScan, it is the task of the QA Department to make sure that the laboratory organisation is robust and capable of handling contingencies. Although the current COVID-19 outbreak is beyond imagination, the Contingency Plan does contain an applicable response plan for an epidemic disease.
We are here to support, and we are determined to deliver sequencing services with the highest quality standards and remain working together and sharing our knowledge to continuously support healthcare professionals, patient diagnostics and the scientific community.
The coronavirus outbreak is impacting the way we live, changing the way we work and transforming the way we communicate with each other. We know that the spread of COVID-19 does not remove the need to access high-quality scientific support and advice.
Thanks to our online platforms and Bio-IT infrastructure, our ongoing projects with laboratories in life science, healthcare and pharmaceutical industries proceed without interruption, despite the challenges many service providers face due to the fast spread of COVID-19.
We express the hope that the situation will progressively go back to normal. Please make sure that you are giving the appropriate attention to your health and that of your family.